- Home
- THRD vs HKD Comparison
THRD vs HKD Comparison
Compare THRD & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- HKD
- Stock Information
- Founded
- THRD 2019
- HKD 2003
- Country
- THRD United States
- HKD France
- Employees
- THRD N/A
- HKD N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- HKD Finance: Consumer Services
- Sector
- THRD Health Care
- HKD Finance
- Exchange
- THRD Nasdaq
- HKD Nasdaq
- Market Cap
- THRD 513.2M
- HKD 595.6M
- IPO Year
- THRD 2022
- HKD 2022
- Fundamental
- Price
- THRD $10.84
- HKD $2.62
- Analyst Decision
- THRD Strong Buy
- HKD
- Analyst Count
- THRD 3
- HKD 0
- Target Price
- THRD $20.33
- HKD N/A
- AVG Volume (30 Days)
- THRD 259.3K
- HKD 312.2K
- Earning Date
- THRD 11-07-2024
- HKD 01-01-0001
- Dividend Yield
- THRD N/A
- HKD N/A
- EPS Growth
- THRD N/A
- HKD N/A
- EPS
- THRD N/A
- HKD 0.33
- Revenue
- THRD N/A
- HKD $27,776,448.00
- Revenue This Year
- THRD N/A
- HKD N/A
- Revenue Next Year
- THRD N/A
- HKD N/A
- P/E Ratio
- THRD N/A
- HKD $7.98
- Revenue Growth
- THRD N/A
- HKD N/A
- 52 Week Low
- THRD $8.08
- HKD $2.55
- 52 Week High
- THRD $16.94
- HKD $5.80
- Technical
- Relative Strength Index (RSI)
- THRD 40.49
- HKD 35.13
- Support Level
- THRD $10.53
- HKD $2.58
- Resistance Level
- THRD $11.84
- HKD $2.87
- Average True Range (ATR)
- THRD 0.86
- HKD 0.18
- MACD
- THRD -0.07
- HKD -0.03
- Stochastic Oscillator
- THRD 17.60
- HKD 9.58
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.